Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide.
This email address is used for sending the document.